RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 88 filers reported holding RAPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,964 | -19.1% | 4,691 | -9.0% | 0.05% | -17.5% |
| Q2 2023 | $96,361 | -4.6% | 5,153 | -6.4% | 0.06% | +1.8% |
| Q1 2023 | $100,980 | -33.1% | 5,503 | -27.8% | 0.06% | -29.1% |
| Q4 2022 | $150,975 | -10.7% | 7,625 | +8.7% | 0.08% | +17.9% |
| Q3 2022 | $169,000 | +33.1% | 7,015 | +0.7% | 0.07% | +42.6% |
| Q2 2022 | $127,000 | +13.4% | 6,964 | +37.0% | 0.05% | -6.0% |
| Q1 2022 | $112,000 | -43.4% | 5,082 | -5.7% | 0.05% | -33.3% |
| Q4 2021 | $198,000 | +20.0% | 5,389 | +1.4% | 0.08% | +2.7% |
| Q3 2021 | $165,000 | -7.3% | 5,312 | -5.0% | 0.07% | 0.0% |
| Q2 2021 | $178,000 | -35.3% | 5,589 | -54.9% | 0.07% | -37.1% |
| Q1 2021 | $275,000 | +14.6% | 12,381 | +1.9% | 0.12% | +16.0% |
| Q4 2020 | $240,000 | -47.9% | 12,155 | -15.1% | 0.10% | -58.7% |
| Q3 2020 | $461,000 | -2.3% | 14,317 | -12.0% | 0.24% | +8.0% |
| Q2 2020 | $472,000 | – | 16,274 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $49,189,395 | 17.79% |
| Euclidean Capital LLC | 432,900 | $7,943,715 | 6.97% |
| GREAT POINT PARTNERS LLC | 1,355,151 | $24,867,021 | 4.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 875,984 | $16,074,306 | 3.02% |
| Trustees of Columbia University in the City of New York | 80,580 | $1,478,643 | 2.64% |
| Perceptive Advisors | 2,291,608 | $42,051,007 | 1.24% |
| Cormorant Asset Management, LP | 650,000 | $11,928 | 0.79% |
| Alphabet Inc. | 540,270 | $9,913,955 | 0.55% |
| Redmile Group, LLC | 688,132 | $12,627,222 | 0.55% |
| Orbimed Advisors | 1,251,070 | $22,957,135 | 0.45% |